Why you should buy Bentham IMF Ltd today

Australia's largest litigation funder is set to grow strongly over the next three years.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Litigation funder Bentham IMF Ltd (ASX:IMF) is the pre-eminent litigation funder operating in Australia and has the largest share of litigation funding business in Australia. Bentham provides funding on a contingency basis to businesses and individuals and in return receives a share of the amount awarded to the client where successful.

Bentham has a competitive advantage over its competitors due to its superior risk mitigation process in selecting cases and case management expertise. This is reflected in the company's results, over the past 12 years Bentham has only lost 4% of cases (out of 155 cases). Over the past 13 years, the company has averaged an impressive 185% return on funds invested in each case (including lost cases).

Bentham looks set for strong growth over the next five years and has identified major growth opportunities both domestically and overseas, including:

  • Confirmation it will fund its largest ever case (the Wivenhoe Dam case);
  • Entering into a joint venture arrangement to fund European litigation, focusing on the UK and the Netherlands markets;
  • Continuing its expansion into the lucrative United States market.

Bentham now has a large investment case portfolio of $2.2 billion as at 31 March 2014, the portfolio's returns are expected to be realised over the next three years. As a result earnings should be significantly higher over the next three years than those achieved in FY13. Trading on a price earnings ratio of just 17 times FY13's earnings, the shares are cheap. Bentham also pays a very attractive dividend yield of 4.9%, which also looks set to increase over the coming years.

Motley Fool contributor Bradley Murphy does not own shares in any company mentioned in this article. 

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »